Search results

1. Mr Oscar Baldwin

   ... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...

2. Dr Saif Ahmad

   I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...

3. Dr Sujath Abbas

   ... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...

4. Professor Walid Khaled

   ... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...

5. Dr David Gilligan

   David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

6. Mr David Thurtle

   Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

7. Dr Roisin Owens

   Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

8. Mr Thierry Lefebvre

   Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

9. Dr Anita Chandra

10. Dr Amy Riddell

11. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

12. Dr Anne-Laure Vallier

    (tbc)

13. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

14. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

15. Dr Emma Beddowes

    Investigating the development and application of circulating free nucleic acids to breast cancer research.

16. Mrs Bin Liu

    Clinical information system

17. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

18. Dr Callum Campbell

19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

20. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

21. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

22. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

23. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

24. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

25. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

26. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

27. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

28. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

29. Dr John Lizhe Zhuang

    ... that initiate BO and OAC. Firstly, I have established a series of patient derided organoid models from normal tissues, BO, and OAC, and ...

30. Professor Ming-Qing Du

    ... and molecular investigations. We have been undertaking a series of research programmes to elucidate the pathology, immunophenotype, and ...

31. Dr David Fairen-Jimenez

    Our research concerns the study of the molecular mechanisms that control adsorption processes in porous materials. We are particularly interested in drug delivery systems, where nanotechnology has a fundamental impact to revolutionise cancer diagnosis...

32. Miss Jamie McGinn

    Project title: Epithelial cell dynamics during postnatal growth; relevance for ...

33. Dr Anny Wong

    ... treatment and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...

34. Professor Kevin Brindle

    Magnetic resonance imaging (MRI) is a well-established, clinically applicable, tool for determining tissue morphology. The techniques of molecular imaging seek, through the use of appropriate probe molecules, to transfer into the MR image of tissue...

35. Professor Charlotte Coles

    ... radiotherapy in patients at low risk of recurrence – in follow up: 2018 patients recruited; 71 UK centres 2. IMPORT HIGH : phase ... IMRT for patients at higher risk of recurrence - in follow up: 2617 patients recruited; 77 UK centres 3. PRIMETIME : ...

36. Mrs Eva Serrao

    ... formed alanine and lactate as a probe to detect, grade and follow progression of precursor lesions of pancreatic cancer before any ...

37. Miss Nicola Fearnhead

    Miss Nicola Fearnhead has been a Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge since 2006. She is a graduate of Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was...

38. Dr George Follows

    My laboratory research focuses on transcriptional regulation and chromatin structure. I maintain a supervisory role for a research assistant in Professor Green's laboratory, CIMR, funded through a personal LRF project grant. I have now taken a clinical...

39. Dr Hannah Harrison

    ... risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating ...

40. Professor Julie Ahringer

    We investigate the functions chromatin regulatory complexes implicated in human disease using the C. elegans model system. These include the histone deacetylase complex NuRD, the Retinoblastoma complex DRM, and a TIP60 histone acetyltransferase complex....

41. Dr John Suckling

    Our research programme leverages two decades of advancements in magnetic resonance imaging and assocaited methodologies to accrue the evidence to inform the difficult discussions with patients with brain tumours, and their families, on the balance...

Pages